Tag: Zogenix

September 9, 2019

Zogenix’ Acquisition of Modis Therapeutics Completes

Zogenix (NASDAQ:ZGNX) has announced its acquisition of Modis Therapeutics has completed and that it has added MT1621 to its late-stage...
December 3, 2018

Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA (ZX008) in Dravet Syndrome

Zogenix (NASDAQ:ZGNX) a pharmaceutical company developing therapies for the treatment of rare diseases, announced today that late-breaking data will be...
August 7, 2018

VIDEO — Life Science Update July 2018

July was a busy month for the life science space. Here the Investing News Network takes a look at what...
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 12, 2018

Zogenix’s Phase 3 Clinical Study Met all Endpoints

Zogenix announced on Thursday (July 12) that its Phase 3 trial of ZX008 in Dravet syndrome met its primary and...
July 12, 2018

Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

Zogenix (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today reported positive...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.